Introduction Semaglutide Has emerged as a revolutionary treatment for individuals dealing with type 2 diabetes, obesity, and related cardiovascular conditions. This medication, classified as a GLP-1 receptor agonist, mimics the natural hormone glucagon-like peptide-1 (GLP-1), which plays a crucial role in regulating insulin secretion, blood sugar levels, and appetite. Initially https://no-1-cancer-scanning-in-i50471.ezblogz.com/63254708/semaglutide-a-breakthrough-medication-for-weight-loss-diabetes-and-heart-health